Details for New Drug Application (NDA): 077867
✉ Email this page to a colleague
NDA 077867 describes SOJOURN, which is a drug marketed by Piramal Critical and is included in one NDA. It is available from two suppliers. Additional details are available on the SOJOURN profile page.
The generic ingredient in SOJOURN is sevoflurane. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
The generic ingredient in SOJOURN is sevoflurane. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
Summary for 077867
| Tradename: | SOJOURN |
| Applicant: | Piramal Critical |
| Ingredient: | sevoflurane |
| Patents: | 0 |
Pharmacology for NDA: 077867
| Physiological Effect | General Anesthesia |
Suppliers and Packaging for NDA: 077867
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SOJOURN | sevoflurane | LIQUID;INHALATION | 077867 | ANDA | Piramal Critical Care Inc | 66794-012 | 66794-012-10 | 100 mL in 1 BOTTLE, GLASS (66794-012-10) |
| SOJOURN | sevoflurane | LIQUID;INHALATION | 077867 | ANDA | Piramal Critical Care Inc | 66794-012 | 66794-012-25 | 250 mL in 1 BOTTLE, GLASS (66794-012-25) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | LIQUID;INHALATION | Strength | 100% | ||||
| Approval Date: | May 2, 2007 | TE: | AN | RLD: | No | ||||
Complete Access Available with Subscription
